Q49A26 (GLYR1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
December 14, 2011.
Version 65.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Putative oxidoreductase GLYR1 EC=1.-.-.- Alternative name(s): 3-hydroxyisobutyrate dehydrogenase-like protein Cytokine-like nuclear factor N-PAC Glyoxylate reductase 1 homolog Nuclear protein NP60 Nuclear protein of 60 kDa | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 553 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May have oxidoreductase activity. Regulates p38 MAP kinase activity by mediating stress activation of p38alpha/MAPK14 and specifically regulating MAPK14 signaling. Indirectly promotes phosphorylation of MAPK14 and activation of ATF2. The phosphorylation of MAPK14 requires upstream activity of MAP2K4 and MAP2K6. Recruited on chromatin, recognizes and binds trimethylated 'Lys-36' of histone H3 (H3K36me3). Ref.1 Ref.12 |
| Subunit structure | Interacts with MAPK14. Ref.1 |
| Subcellular location | |
| Domain | The A.T hook DNA-binding domain is required for the interaction with MAPK14. Ref.1 Ref.12 The PWWP domain probably mediates the binding to H3K36me3. Ref.1 Ref.12 |
| Miscellaneous | The conserved NAD-binding sites and sequence similarity to plant dehydrogenases suggest that this protein may have oxidoreductase activity. |
| Sequence similarities | Belongs to the 3-hydroxyisobutyrate dehydrogenase family. NP60 subfamily. Contains 1 A.T hook DNA-binding domain. Contains 1 PWWP domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Ligand | DNA-binding NAD |
| Molecular function | Oxidoreductase |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | pentose-phosphate shunt Inferred from electronic annotation. Source: InterPro |
| Cellular component | nucleus Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | DNA binding Inferred from electronic annotation. Source: UniProtKB-KW coenzyme bindingInferred from electronic annotation. Source: InterPro methylated histone residue bindingInferred from direct assay Ref.12. Source: UniProtKB nucleotide bindingInferred from electronic annotation. Source: InterPro phosphogluconate dehydrogenase (decarboxylating) activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q49A26-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q49A26-2) The sequence of this isoform differs from the canonical sequence as follows: 228-244: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 5 (identifier: Q49A26-5) The sequence of this isoform differs from the canonical sequence as follows: 99-179: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q49A26-3) The sequence of this isoform differs from the canonical sequence as follows: 303-308: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: Q49A26-4) The sequence of this isoform differs from the canonical sequence as follows: 1-69: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 553 | 553 | Putative oxidoreductase GLYR1 | PRO_0000312121 | ||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 8 – 66 | 59 | PWWP | |||||||||||||||||||||||||||||||||||||||||||||||||
| DNA binding | 168 – 180 | 13 | A.T hook | |||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 271 – 285 | 15 | NAD By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 362 | 1 | NAD By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 505 | 1 | NAD By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 25 | 1 | N6-acetyllysine Ref.11 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 130 | 1 | Phosphoserine Ref.8 Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 132 | 1 | Phosphoserine Ref.8 Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 167 | 1 | Phosphoserine Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 540 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 69 | 69 | Missing in isoform 4. | VSP_029706 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 99 – 179 | 81 | Missing in isoform 5. | VSP_038222 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 228 – 244 | 17 | Missing in isoform 2. | VSP_029707 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 303 – 308 | 6 | Missing in isoform 3. | VSP_029708 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 103 | 1 | N → D. Corresponds to variant rs34176249 [ dbSNP | Ensembl ]. | VAR_037403 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 459 | 1 | H → Q. Ref.1 Ref.2 Ref.3 Ref.4 Ref.6 Ref.7 Corresponds to variant rs2085329 [ dbSNP | Ensembl ]. | VAR_037404 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 531 | 1 | Y → C. Corresponds to variant rs17703111 [ dbSNP | Ensembl ]. | VAR_037405 | ||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 40 | 1 | K → E in AAH32855. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 419 | 1 | A → T in AAH47223. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 463 | 1 | Q → R in AAH47223. Ref.7 | |||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 283 – 288 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 300 – 303 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 304 – 308 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 317 – 323 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 325 – 329 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 334 – 341 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 356 – 359 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 365 – 377 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 382 – 384 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 391 – 395 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 399 – 404 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 410 – 413 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 414 – 419 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 422 – 426 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 433 – 443 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 447 – 452 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 456 – 460 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 465 – 473 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 480 – 490 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 497 – 499 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 500 – 512 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 522 – 536 | 15 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 544 – 550 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Nuclear protein NP60 regulates p38 MAPK activity." Fu J., Yang Z., Wei J., Han J., Gu J. J. Cell Sci. 119:115-123(2006) [PubMed: 16352664] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, DOMAIN, INTERACTION WITH MAPK14, VARIANT GLN-459. |
| [2] | "Molecular characterization of a novel human PWWP domain containing protein with homology to 3-hydroxyisobutyrate dehydrogenase." Watari Y., Tsujino T., Nonaka H., Shirai Y., Saito N., Yokoyama M. Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT GLN-459. |
| [3] | "A novel cytokine-like nuclear factor, N-PAC." New L., Han J. Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), VARIANT GLN-459. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5), VARIANT GLN-459. Tissue: Tongue. |
| [5] | "The sequence and analysis of duplication-rich human chromosome 16." Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J. Pennacchio L.A.Nature 432:988-994(2004) [PubMed: 15616553] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT GLN-459. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 14-553 (ISOFORM 2), VARIANT GLN-459. Tissue: Brain, Lymph, Placenta and Testis. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130; SER-132 AND SER-167, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130 AND SER-132, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-540, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [11] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-25, MASS SPECTROMETRY. |
| [12] | "Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers." Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S., Butter F., Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G., Mann M. Cell 142:967-980(2010) [PubMed: 20850016] [Abstract] Cited for: DOMAIN PWWP, FUNCTION. |
| [13] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [14] | "The structure of the cytokine-like nuclear factor N-PAC." Structural genomics consortium (SGC) Submitted (FEB-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 261-553 IN COMPLEX WITH NAD ANALOG. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AY352585 mRNA. Translation: AAQ57265.1. AF244907 mRNA. Translation: AAQ14242.1. AF326966 mRNA. Translation: AAK15524.1. AK296842 mRNA. Translation: BAG59409.1. AC020663 Genomic DNA. No translation available. CH471112 Genomic DNA. Translation: EAW85252.1. CH471112 Genomic DNA. Translation: EAW85257.1. BC003693 mRNA. Translation: AAH03693.1. BC032855 mRNA. Translation: AAH32855.1. BC047223 mRNA. Translation: AAH47223.1. BC064940 mRNA. Translation: AAH64940.1. | ||||||||||||
| IPI | IPI00000155. IPI00644210. IPI00647134. IPI00647648. IPI00910934. | ||||||||||||
| RefSeq | NP_115958.2. NM_032569.3. | ||||||||||||
| UniGene | Hs.387255. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q49A26. | ||||||||||||
| SMR | Q49A26. Positions 4-91, 262-553. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q49A26. 4 interactions. | ||||||||||||
| MINT | MINT-3063171. | ||||||||||||
| STRING | Q49A26. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q49A26. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 269849681. | ||||||||||||
Proteomic databases | |||||||||||||
| PRIDE | Q49A26. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000321919; ENSP00000322716; ENSG00000140632. ENST00000436648; ENSP00000390276; ENSG00000140632. | ||||||||||||
| GeneID | 84656. | ||||||||||||
| KEGG | hsa:84656. | ||||||||||||
| UCSC | uc002cxx.2. human. uc002cxz.1. human. uc002cya.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 84656. | ||||||||||||
| GeneCards | GC16M004794. | ||||||||||||
| H-InvDB | HIX0023256. | ||||||||||||
| HGNC | HGNC:24434. GLYR1. | ||||||||||||
| HPA | CAB017022. | ||||||||||||
| MIM | 610660. gene. | ||||||||||||
| neXtProt | NX_Q49A26. | ||||||||||||
| PharmGKB | PA165450093. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG06496. | ||||||||||||
| GeneTree | ENSGT00530000063270. | ||||||||||||
| HOGENOM | HBG729179. | ||||||||||||
| InParanoid | Q49A26. | ||||||||||||
| OMA | HTSADDK. | ||||||||||||
| OrthoDB | EOG45B1F6. | ||||||||||||
| PhylomeDB | Q49A26. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q49A26. | ||||||||||||
| Bgee | Q49A26. | ||||||||||||
| Genevestigator | Q49A26. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR015815. 3hydroxyacid_DH/Rdtase. IPR008927. 6-PGluconate_DH_C-like. IPR006115. 6PGDH_NADP-bd. IPR017956. AT_hook_DNA-bd_motif. IPR013328. DH_multihelical. IPR016040. NAD(P)-bd_dom. IPR000313. PWWP. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:3.40.50.720. NAD(P)-bd. 1 hit. G3DSA:1.10.1040.10. Opine_DH. 1 hit. | ||||||||||||
| PANTHER | PTHR22981. 3hydroxy_acid_DH. 1 hit. | ||||||||||||
| Pfam | PF03446. NAD_binding_2. 1 hit. PF00855. PWWP. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00384. AT_hook. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF48179. 6DGDH_C_like. 1 hit. | ||||||||||||
| PROSITE | PS00895. 3_HYDROXYISOBUT_DH. False negative. PS50812. PWWP. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 74618. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | GLYR1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q49A26 Secondary accession number(s): B4DL47 Q9BXK2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with